Keywords: بسیج بنیادی; Substance P; High-density lipoprotein; Stem cell mobilization; Diabetic peripheral ischemia; Therapeutic angiogenesis;
مقالات ISI بسیج بنیادی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بسیج بنیادی; Allogeneic stem cell transplantation; Peripheral bood stem cell; Stem cell mobilization;
Keywords: بسیج بنیادی; Stem cells; Lung regeneration; Stem cell mobilization; Pulmonary emphysema;
Keywords: بسیج بنیادی; Hematopoietic stem cells; Stem cell mobilization; G-CSF; Plerixafor; Ex vivo expansion; Umbilical cord blood;
Keywords: بسیج بنیادی; AL amyloidosis; Stem cell mobilization; Cyclophosphamide, doxorubicin, dexamethasone (CAD); Granulocyte colony-stimulating factor; Peripheral blood stem cells collection;
Keywords: بسیج بنیادی; Seminiferous tubule auto-regeneration; Malnutrition; Stem cell mobilization; Bee honey
Keywords: بسیج بنیادی; Stem cell mobilization; Etoposide; Plerixafor; Autologous stem cell transplantation
Keywords: بسیج بنیادی; Stem cell mobilization; G-CSF; Plerixafor; SDF-1; Parathyroid hormone
Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens
Keywords: بسیج بنیادی; Autologous stem cell transplantation (ASCT); Multiple myeloma (MM); Stem cell mobilization; Novel induction regimens; Remission status;
Orchestration of Chemomobilization and G-CSF Administration for Successful Hematopoietic Stem Cell Collection
Keywords: بسیج بنیادی; G-CSF; Stem cell mobilization; PBSC; Chemomobilization;
Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report
Keywords: بسیج بنیادی; Plerixafor; Multiple myeloma; Non-Hodgkin lymphoma; Long-term follow-up; Stem cell mobilization;
Biosimilar filgrastim (leucostim®) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen®) and lenograstim (granocyte®): A retrospective multicenter study
Keywords: بسیج بنیادی; Autologous hematopoietic cell transplantation; Stem cell mobilization; G-CSF; Biosimilars;
Allogeneic: AdultEvaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation
Keywords: بسیج بنیادی; Plerixafor; Mozobil; AMD-3100; Autologous stem cell transplant; Stem cell mobilization;
Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of Granulocyte Colony-Stimulating Factor in Lymphoma Patients Undergoing Autologous Stem Cell Collection
Keywords: بسیج بنیادی; Non-Hodgkin lymphoma; Hodgkin lymphoma; Plerixafor; Stem cell mobilization; Autologous stem cell transplant;
DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience
Keywords: بسیج بنیادی; DHAP plus filgrastim; Stem cell mobilization; Lymphoma;
Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34+ peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant
Keywords: بسیج بنیادی; Allogeneic hematopoietic stem cell transplantation; Stem cell mobilization; G-CSF; Biosimilars
Autologous Stem Cell Mobilization in the Age of Plerixafor
Keywords: بسیج بنیادی; Growth factors; Hematopoietic stem cell transplantation; Multiple myeloma; Plerixafor; Stem cell mobilization;
Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial
Keywords: بسیج بنیادی; Myeloma; Stem cell transplant; Stem cell mobilization;
Optimizing mobilization strategies in difficult-to-mobilize patients: The role of plerixafor
Keywords: بسیج بنیادی; Plerixafor; Stem cell mobilization; Hard-to-mobilize patients
SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
Keywords: بسیج بنیادی; SHIP1; 3AC; Allogeneic BMT; Autologous BMT; Stem cell mobilization; SDF-1; MMP-9; NK cells; SHIPi
R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma
Keywords: بسیج بنیادی; R-ESHAP; Pegfilgrastim; Stem cell mobilization; CD34+ collection; Diffuse large B-cell lymphoma;
The effect of gradual increment in rhG-CSF dose on stem cell yields in patients with multiple myeloma mobilized with intermediate dose cyclophosphamide plus rhG-CSF
Keywords: بسیج بنیادی; Multiple myeloma; Stem cell mobilization; Granulocyte colony stimulating factor; Cyclophosphamide
Plerixafor and Abbreviated-Course Granulocyte Colony–Stimulating Factor for Mobilizing Hematopoietic Progenitor Cells in Light Chain Amyloidosis
Keywords: بسیج بنیادی; Plerixafor; Granulocyte colony–stimulating factor (G-CSF); Light chain amyloidosis (AL amyloidosis); Stem cell mobilization
Prediction of Poor Mobilization of Autologous CD34+ Cells with Growth Factor in Multiple Myeloma Patients: Implications for Risk-Stratification
Keywords: بسیج بنیادی; Stem cell mobilization; Multiple myeloma; CD34; Filgrastim; Plerixafor
High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Conso
Keywords: بسیج بنیادی; Cyclophosphamide; Etoposide; Platinum; Stem cell mobilization; Non-Hodgkin lymphoma
G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent
Keywords: بسیج بنیادی; G-CSF; Stem cell mobilization; Chemotherapy; Stem cell transplantation; Bone marrow microenvironment;
The difference in lactate dehydrogenase activity between pre- and post-mobilization periods is a good indicator of successful stem cell mobilization
Keywords: بسیج بنیادی; Lactate dehydrogenase; Risk factor; Stem cell mobilization
Mobilization and collection of peripheral blood stem cells in healthy donors: Risks, adverse events and follow-up
Keywords: بسیج بنیادی; Granulocyte-colony-stimulating factor; Healthy donors; Follow-up; Stem cell mobilization; Allogeneic stem cell transplantationFacteur de croissance hématopoïétique; Donneurs volontaires; Suivi médical; Mobilisation de cellules souches hématopoïétiques; Al
The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience f
Keywords: بسیج بنیادی; Autologous hematopoietic stem cell transplantation; Stem cell mobilization; G-CSF; Biosimilars
Cost-Effectiveness Analysis of a Risk-Adapted Algorithm of Plerixafor Use for Autologous Peripheral Blood Stem Cell Mobilization
Keywords: بسیج بنیادی; Plerixafor; Cost effective analysis; Risk-adapted algorithm; Stem cell mobilization
An emerging link in stem cell mobilization between activation of the complement cascade and the chemotactic gradient of sphingosine-1-phosphate
Keywords: بسیج بنیادی; S1P; SDF-1; CXCR4; Stem cell mobilization; MAC
Plerixafor use in patients with previous mobilization failure: A multicenter experience
Keywords: بسیج بنیادی; Plerixafor; Stem cell mobilization; Mobilization failure; Chemotherapy
The effect of cholesterol levels on hematopoietic stem cell mobilization
Keywords: بسیج بنیادی; Cholesterol; Stem cell mobilization;
Risk factors for unsuccessful peripheral blood stem cell harvesting using granulocyte-colony stimulating factor mobilization in patients with multiple myeloma
Keywords: بسیج بنیادی; Stem cell mobilization; Multiple myeloma; Risk factors;
The use of plerixafor in hematopoietic progenitor cell collection in pediatric patients: a single center experience
Keywords: بسیج بنیادی; AMD3100; pediatric; plerixafor; poor mobilizers; stem cell mobilization;
Who should be really considered as a poor mobilizer in the plerixafor era?
Keywords: بسیج بنیادی; Poor mobilizers; Stem cell mobilization; CD34+ cells
Mobilized Peripheral Blood Stem Cells Compared with Bone Marrow as the Stem Cell Source for Unrelated Donor Allogeneic Transplantation with Reduced-Intensity Conditioning in Patients with Acute Myeloid Leukemia in Complete Remission: An Analysis from the
Keywords: بسیج بنیادی; Acute myelogenous leukemia; Allogeneic stem cell transplant; Reduced-intensity conditioning; Stem cell mobilization; Remission
Plerixafor Plus Granulocyte Colony-Stimulating Factor versus Placebo Plus Granulocyte Colony-Stimulating Factor for Mobilization of CD34+ Hematopoietic Stem Cells in Patients with Multiple Myeloma and Low Peripheral Blood CD34+ Cell Count: Results of a Su
Keywords: بسیج بنیادی; Stem cell mobilization; Poor mobilzer; AMD 3100
Systematic Review of Randomized Controlled Trials of Hematopoietic Stem Cell Mobilization Strategies for Autologous Transplantation for Hematologic Malignancies
Keywords: بسیج بنیادی; Hematopoietic stem cell transplantation; Stem cell mobilization; Mobilization strategy; Plerixafor
Late Afternoon Dosing of Plerixafor for Stem Cell Mobilization: A Practical Solution
Keywords: بسیج بنیادی; Autologous transplant; Lenalidomide; Plerixafor; Stem cell mobilization
Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy
Keywords: بسیج بنیادی; Stem cell mobilization; Myeloma; Etoposide; Lenalidomide; Autologous stem cell transplantation
Can every patient be mobilized?
Keywords: بسیج بنیادی; stem cell mobilization; autologous; allogeneic; plerixafor; G-CSF; GM-CSF;
Plerixafor (Mozobil®) Alone to Mobilize Hematopoietic Stem Cells from Multiple Myeloma Patients for Autologous Transplantation
Keywords: بسیج بنیادی; AMD3100; Plerixafor; Autologous transplantation; Stem cell mobilization; Multiple myeloma
Increased adenosine triphosphate production by peripheral blood CD4+ cells in patients with hematologic malignancies treated with stem cell mobilization agents
Keywords: بسیج بنیادی; Stem cell transplantation; Stem cell mobilization; CD4 + T-cell activation; Adenosine triphosphate production
Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation
Keywords: بسیج بنیادی; Stem cell mobilization; Stem cell transplantation; Poor mobilizer
Evaluation of mobilized peripheral blood CD34+ cells from patients with severe coronary artery disease as a source of endothelial progenitor cells
Keywords: بسیج بنیادی; coronary artery disease; endothelial progenitor cells; stem cell mobilization; transplant
Impairment of Filgrastim-Induced Stem Cell Mobilization after Prior Lenalidomide in Patients with Multiple Myeloma
Keywords: بسیج بنیادی; Stem cell mobilization; Autotransplant; Myeloma
Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient
Keywords: بسیج بنیادی; Stem cell mobilization; Plerixafor; Hard to mobilize
IGF-1 and G-CSF complement each other in BMSC migration towards infarcted myocardium in a novel in vitro model
Keywords: بسیج بنیادی; Bone marrow stem cells; Cytokines; Granulocyte-colony stimulating factor; Stem cell factor; Insulin-like growth factor-1; Stem cell mobilization;
Successful Stem Cell Remobilization Using Plerixafor (Mozobil) Plus Granulocyte Colony-Stimulating Factor in Patients with Non-Hodgkin Lymphoma: Results from the Plerixafor NHL Phase 3 Study Rescue Protocol
Keywords: بسیج بنیادی; Plerixafor; Stem cell mobilization; NHL;